Hardt K, Vandebosch A, Sadoff J, Le Gars M, et al. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Infect Dis 2022 Sep 13. pii: S1473-3099(22)00506.
PMID: 36113538